GDC-0994

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for GDC-0994, covering 2018-04-06 to 2018-08-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Safety, Tolerability, and Effects of Cobimetinib and GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1]

See pricing